OPGN - OpGen, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Rockville,
United States
Type: Equity
OPGN price evolution
OPGN
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.17 | $0.27 | $1.15 | $0.29 |
| Short term investments | ||||
| Net receivables | $0.03 | $0.04 | $0.1 | $0.42 |
| Inventory | $2.81 | |||
| Total current assets | $0.57 | $0.53 | $1.58 | $3.45 |
| Long term investments | ||||
| Property, plant & equipment | $1.99 | $0 | $5.74 | |
| Goodwill & intangible assets | $6.84 | |||
| Total noncurrent assets | $2.3 | $2.44 | $0.3 | $14.68 |
| Total investments | ||||
| Total assets | $2.87 | $2.97 | $1.88 | $18.13 |
| Current liabilities | ||||
| Accounts payable | $0.13 | $0.19 | $0.11 | $0.9 |
| Deferred revenue | $0.01 | $0.03 | $0.19 | |
| Short long term debt | $11.53 | $11.07 | $11.02 | $9.72 |
| Total current liabilities | $12.6 | $11.7 | $11.42 | $12.47 |
| Long term debt | $1.94 | $1.98 | $2.02 | $2.83 |
| Total noncurrent liabilities | $1.94 | $1.98 | $2.02 | $2.99 |
| Total debt | $13.47 | $13.06 | $13.04 | $12.55 |
| Total liabilities | $14.54 | $13.68 | $13.44 | $15.46 |
| Shareholders' equity | ||||
| Retained earnings | -$306.78 | -$305.11 | -$305.49 | -$288.45 |
| Other shareholder equity | -$0.08 | -$0.68 | ||
| Total shareholder equity | -$11.67 | -$10.71 | -$11.56 | $2.68 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.15 | $7.44 | $36.08 | $13.36 |
| Short term investments | ||||
| Net receivables | $0.1 | $0.51 | $1.17 | $0.65 |
| Inventory | $1.35 | $4.71 | $3.17 | |
| Total current assets | $1.58 | $10.66 | $39.74 | $16.89 |
| Long term investments | ||||
| Property, plant & equipment | $0 | $4.92 | $5.92 | $5.79 |
| Goodwill & intangible assets | $7.44 | $21.98 | $24.61 | |
| Total noncurrent assets | $0.3 | $15.16 | $31.92 | $32.86 |
| Total investments | ||||
| Total assets | $1.88 | $25.81 | $71.67 | $49.75 |
| Current liabilities | ||||
| Accounts payable | $0.11 | $0.42 | $1.31 | $1.87 |
| Deferred revenue | $0.03 | $0.14 | $0.01 | |
| Short long term debt | $11.02 | $7.4 | $15.02 | $1.93 |
| Total current liabilities | $11.42 | $10.59 | $19.92 | $7.37 |
| Long term debt | $2.02 | $4.85 | $10.16 | $20.92 |
| Total noncurrent liabilities | $2.02 | $7.65 | $10.53 | $21.19 |
| Total debt | $13.04 | $14.82 | $25.18 | $22.85 |
| Total liabilities | $13.44 | $18.24 | $30.45 | $28.56 |
| Shareholders' equity | ||||
| Retained earnings | -$305.49 | -$272.82 | -$235.54 | -$200.74 |
| Other shareholder equity | -$0.08 | -$0.8 | $0.59 | $2.55 |
| Total shareholder equity | -$11.56 | $7.58 | $41.22 | $21.19 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.03 | $0.17 | $1.07 | $0.7 |
| Cost of revenue | -$0.04 | $0.07 | $1.18 | $0.69 |
| Gross Profit | $0.07 | $0.09 | -$0.11 | $0.01 |
| Operating activities | ||||
| Research & development | $0.02 | $0.03 | $0.33 | $1.2 |
| Selling, general & administrative | $1.59 | $1.77 | $1.46 | $2.37 |
| Total operating expenses | $1.62 | $1.8 | $3.87 | $3.57 |
| Operating income | -$1.55 | -$1.7 | -$3.98 | -$3.57 |
| Income from continuing operations | ||||
| EBIT | -$1.58 | $0.39 | -$16.9 | -$3.67 |
| Income tax expense | ||||
| Interest expense | $0 | $0.14 | $0.4 | |
| Net income | ||||
| Net income | -$1.58 | $0.39 | -$17.04 | -$4.06 |
| Income (for common shares) | -$1.58 | $0.27 | -$17.04 | -$4.06 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.42 | $2.61 | $4.31 | $4.21 |
| Cost of revenue | $3.51 | $3.42 | $2.85 | $3.85 |
| Gross Profit | -$0.09 | -$0.82 | $1.46 | $0.37 |
| Operating activities | ||||
| Research & development | $4.73 | $8.17 | $10.91 | $9.96 |
| Selling, general & administrative | $10.86 | $13.23 | $13.65 | $11.9 |
| Total operating expenses | $17.68 | $33.75 | $24.73 | $23.08 |
| Operating income | -$17.77 | -$34.57 | -$23.27 | -$22.72 |
| Income from continuing operations | ||||
| EBIT | -$30.83 | -$34.03 | -$29.96 | -$22.68 |
| Income tax expense | $0.04 | $0.13 | ||
| Interest expense | $1.84 | $3.26 | $4.8 | $3.4 |
| Net income | ||||
| Net income | -$32.67 | -$37.28 | -$34.81 | -$26.21 |
| Income (for common shares) | -$32.67 | -$37.28 | -$41.97 | -$26.21 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$1.58 | $0.39 | -$17.04 | -$4.06 |
| Operating activities | ||||
| Depreciation | $0.04 | $0 | $0.25 | $0.35 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.37 | $0.19 | $0.1 | -$0.23 |
| Total cash flows from operations | -$0.72 | -$1.08 | -$1.68 | -$2.93 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0.1 | ||
| Investments | ||||
| Total cash flows from investing | -$0 | -$0.1 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.85 | $0.03 | ||
| Net borrowings | $0.27 | -$0 | -$0.01 | -$0 |
| Total cash flows from financing | $0.62 | $0.2 | $2.1 | $0.03 |
| Effect of exchange rate | $0.25 | $0.05 | ||
| Change in cash and equivalents | -$0.1 | -$0.88 | $0.67 | -$2.95 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$32.67 | -$37.28 | -$34.81 | -$26.21 |
| Operating activities | ||||
| Depreciation | $1.32 | $1.64 | $2.71 | $2.33 |
| Business acquisitions & disposals | $1.27 | |||
| Stock-based compensation | $0.52 | $0.95 | $0.88 | $0.32 |
| Total cash flows from operations | -$14.32 | -$20.45 | -$21.48 | -$23.4 |
| Investing activities | ||||
| Capital expenditures | -$0.8 | -$0.59 | -$1.98 | -$0.13 |
| Investments | -$2.2 | |||
| Total cash flows from investing | -$0.8 | -$0.59 | -$1.98 | -$1.06 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $12.04 | $4.07 | $34.31 | $33.79 |
| Net borrowings | -$3.92 | -$10.81 | -$0.71 | $0.29 |
| Total cash flows from financing | $8.37 | -$6.74 | $47.45 | $34.09 |
| Effect of exchange rate | $0.27 | -$0.92 | -$1.46 | $1.59 |
| Change in cash and equivalents | -$6.48 | -$28.7 | $22.52 | $11.21 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $1.96M |
|---|---|
| EBITDA | -$21.12M |
| EBIT | -$21.76M |
| Net Income | -$22.29M |
| Revenue Q/Q | -96.20% |
| Revenue Y/Y | -30.32% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -344.89% |
| ROE | 285.24% |
| Debt/Equity | -1.16 |
|---|---|
| Net debt/EBITDA | -0.68 |
| Current ratio | 0.05 |
| Quick ratio | 0.05 |